To explore the regulatory mechanism of SERCA2a under NBP treatment, we demonstrated that the expression of SERCA2a was reduced in HF mice (Figure 3(a)), leading to Ca2+ transport disorder, resulting in inhibited levels of calmodulin, DHPR, and Cav1.2 (Figure 3(a)). This evidence concerns the gene CACNA1C and hydrops fetalis.